Oranda Therapeutics is focused on developing novel therapeutic agents for unmet medical needs. The company utilizes advanced preclinical research to identify and validate new drug candidates. Their work aims to translate scientific discoveries into viable treatments for complex diseases.
Funding
$37.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many patients in Europe with rare, life-threatening, or chronically debilitating diseases lack access to essential medicines due to challenges in commercializing and distributing these therapies. BioPharma SMEs often face difficulties in navigating the complexities of European market access, hindering the availability of innovative treatments for those who need them most.
Solution
Oranda Therapeutics specializes in acquiring and commercializing late-stage rare disease therapies, focusing on improving patient access to these medicines across Europe. The company partners with BioPharma SMEs to bring innovative medicines to patients with unmet medical needs. By leveraging expertise in market access, pricing, reimbursement, and product licensing, Oranda Therapeutics aims to bridge the gap between pharmaceutical innovation and patient availability, ensuring that essential treatments reach those who can benefit from them.
Target Audience
The primary target audience includes BioPharma SMEs with innovative rare disease therapies seeking to commercialize their products in the European market, as well as European patients with rare, life-threatening, or chronically debilitating conditions who lack access to essential medicines.
Features
- Expertise in European market access for rare disease therapies
- Focus on commercializing late-stage products to expedite patient access
- Strategic partnerships with BioPharma SMEs to expand product portfolios
- Specialization in pricing and reimbursement strategies across diverse European markets
- Streamlined distribution channels to ensure efficient delivery of medicines